TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry | #o | #f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
7/6/26 16:06 | 6/30/26 | ABSI | Absci Corp | Health | Biolab | Commercial Physical & Biologi | 5 | 8 | P | 1,367 | 3.25 | 0 | 421 | 85 | 919 | D | |||||||||||||||
6/24/26 09:00 | 6/23/26 | ONMD | Onemednet Corp | DE | Health | Biolab | Commercial Physical & Biologi | 5 | 14 | P.dm | 4,177 | 0.6353 | 0 | 6,574 | 28 | 29,736 | D | ||||||||||||||
3/4/26 16:39 | 3/3/26 | CRL | Charles River Laboratories International, Inc. | Health | Biolab | Commercial Physical & Biologi | 1 | 1 | P | 4 | 174.56 | 0 | 0 | 0 | 27 | D | |||||||||||||||
2/19/26 17:02 | 2/17/26 | NRC | National Research Corp | DE | Health | Biolab | Commercial Physical & Biologi | 3 | 3 | P | 142 | 12.61 | 0 | 11 | 6 | 195 | I | ||||||||||||||
11/10/25 08:30 | 3/21/25 | OABI | Omniab, Inc. | DE | Health | Biolab | Commercial Physical & Biologi | 3 | 6 | P.m | 588 | 1.80 | 0 | 327 | 12 | 3,113 | D | ||||||||||||||
8/13/25 19:48 | 8/13/25 | MXCT | Maxcyte, Inc. | DE | Health | Biolab | Commercial Physical & Biologi | 4 | 4 | P | 369 | 1.34 | 0 | 275 | 45 | 886 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |